• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

233
229
183
171
152

COUNTRY

173
53
40
35
12

CATEGORIES

  • 339
  • 242
  • 208
  • 101
  • 58
  • 32
  • 28
  • 26
  • 21
  • 17
  • 11
  • 11
  • 10
  • 10
  • 10
  • 9
  • 7
  • 6
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

637
741
869
1,058

PUBLISHED

14
42
194
1,058

PRODUCT TYPE

599
240
212
6
1

Search "Pfizer Inc.-Financial Company Report" returned 1,058 results.

Pfizer Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Pfizer Inc. Company Profile” is a comprehensive report on Pfizer Inc.. The report provides complete information on the operations, organization structure and financial information details of the company....

October 2014
FROM

Pfizer Inc. - Strategy and SWOT Report

Pfizer Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

December 2014
FROM

Pfizer Inc. - Product Pipeline Review - 2013

Pfizer Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Pfizer Inc. - Product Pipeline Review - 2013” provides data on the Pfizer Inc.’s research and development...

April 2013
FROM

Pfizer Inc. - Product Pipeline Review - 2012

Pfizer Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Pfizer Inc. - Product Pipeline Review - 2012” provides data on the Pfizer Inc.’s research and development...

October 2012
FROM

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

March 2015
FROM

Strategic Importance of Intellectual Property (IP) in M&A

The report highlights strategic importance of intellectual property (IP) in Merger and acquisition (M&A) deals. The study analyzes recent IP-driven M&A deals, and pinpoints key role that IP assets and...

March 2015
FROM

Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis

The global pharmaceutical industry is expected to reach $1,241 billion by 2016, growing at a CAGR of 5 7% The fragmented market has observed some changes in the competitive landscape during the last...

December 2012
FROM

Credit FAQ: How Does Standard & Poor's View Pfizer Inc.'s Proposed Merger With AstraZeneca? Apr 14

Abstract On April 29, 2014, Standard & Poor's Ratings Services said its ratings on New York-based Pfizer Inc. are unchanged at this time following Pfizer's proposal to merge with AstraZeneca in a deal...

April 2014

Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

'Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'...

October 2013
FROM

Global Hemophilia Market Report: 2013 Edition

Hemophilia is a disorder in which the blood does not clot properly, leading to extended bleeding. The bleeding can be external or internal, especially in the knees, ankles, and elbows. There are two...

October 2013
FROM

Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer...

February 2015
FROM

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered...

April 2014
FROM

Bulletin: Pfizer Inc.'s Planned Acquisition Of Hospira Does Not Affect Ratings Feb 15

Abstract TORONTO (Standard & Poor's) Feb. 5, 2015--Standard & Poor's Ratings Services today said that New York City-based Pfizer Inc.'s announcement that it is acquiring Lake Forest, Ill.-based specialty...

February 2015

The US Specialty Pharmaceutical Market Report: 2013 Edition

Specialty pharmaceuticals are defined as a new, rapidly growing drugs and biologics that are manufactured as a result of continued advancements in drug technology and design These pharmaceuticals are...

February 2014
FROM

Pfizer Inc.: SWOT Analysis & Company Profile

Synopsis Business Review’s Pfizer Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company...

September 2010
FROM

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – Pipeline Forecast & Market Forecast in G8 Countries (2011 – 2020)

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential with increasing incidence rate of the disease across the globe The incidence of acute lymphocytic/lymphoblastic...

December 2013
FROM

The US Specialty Pharmaceutical Market Report: 2015 Edition

Specialty pharmaceuticals are typically high-cost, scientifically engineered drugs used to treat complex, chronic conditions that require special storage, warranting special handling, and temperature-control...

March 2015
FROM

Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries.

Lung cancer is responsible for most of the deaths (due to cancer) across the globe With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer;...

November 2011
FROM
Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018 Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018 - Product Thumbnail Image

Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

'Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics And Anti-Migraine Agents) - Global Industry Analysis, Size, Share,...

July 2013
FROM
Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012-2018 Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012-2018 - Product Thumbnail Image

Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012-2018

'Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012...

July 2013
FROM
Loading Indicator

Our Clients

Procter & Gamble Co. Western Union Company Volvo Car Corporation Morgan Stanley SAP SE LG Corporation Roche Diagnostics Ltd.